These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7727061)

  • 1. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA.
    Bechert T; Diekmann S; Arndt-Jovin DJ
    J Biomol Struct Dyn; 1994 Dec; 12(3):605-23. PubMed ID: 7727061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-molecule study of DNA unlinking by eukaryotic and prokaryotic type-II topoisomerases.
    Charvin G; Bensimon D; Croquette V
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9820-5. PubMed ID: 12902541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of Drosophila DNA topoisomerase II with left-handed Z-DNA in supercoiled minicircles.
    Glikin GC; Jovin TM; Arndt-Jovin DJ
    Nucleic Acids Res; 1991 Dec; 19(25):7139-44. PubMed ID: 1662808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
    Harker WG; Slade DL; Parr RL; Holguin MH
    Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of anti-poly[d(G-br5C)] IgG with synthetic, viral and cellular Z DNAs.
    Zarling DA; Arndt-Jovin DJ; McIntosh LP; Robert-Nicoud M; Jovin TM
    J Biomol Struct Dyn; 1984 Mar; 1(5):1081-107. PubMed ID: 6400813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous and heterologous protein-protein interactions of human DNA topoisomerase IIalpha.
    Kroll DJ
    Arch Biochem Biophys; 1997 Sep; 345(2):175-84. PubMed ID: 9308887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
    Chen M; Beck WT
    Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
    Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z-DNA binding and inhibition by GTP of Drosophila topoisomerase II.
    Arndt-Jovin DJ; Udvardy A; Garner MM; Ritter S; Jovin TM
    Biochemistry; 1993 May; 32(18):4862-72. PubMed ID: 8387819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.
    Mirski SE; Gerlach JH; Cole SP
    Exp Cell Res; 1999 Sep; 251(2):329-39. PubMed ID: 10471318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human topoisomerase II-DNA interaction study by using atomic force microscopy.
    Alonso-Sarduy L; Roduit C; Dietler G; Kasas S
    FEBS Lett; 2011 Oct; 585(19):3139-45. PubMed ID: 21907712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity plays an important role in uncoupling the catalytic and scaffolding activities of rat testis DNA topoisomerase IIalpha.
    Bakshi R; Galande S; Muniyappa K
    J Biomol Struct Dyn; 2001 Apr; 18(5):749-60. PubMed ID: 11334111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analysis of the chiral action of type II DNA topoisomerases.
    Klenin K; Langowski J; Vologodskii A
    J Mol Biol; 2002 Jul; 320(2):359-67. PubMed ID: 12079392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
    Gieseler F; Glasmacher A; Kämpfe D; Wandt H; Nuessler V; Valsamas S; Kunze J; Wilms K
    Leukemia; 1996 Jul; 10(7):1177-80. PubMed ID: 8683999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 4. Topotecan binds preferably to the GC base pairs of DNA].
    Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Kudelina IA; Zhuze AL
    Mol Biol (Mosk); 2002; 36(5):912-30. PubMed ID: 12391856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
    Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.